Novo Holdings invests EUR 86 million in 21st.BIO, a new bioindustrial scale-up company building on technology base from Novozymes COPENHAGEN, DENMARK — December 21, 2021. Novo Holdings, a leading international life sciences investor, today announced a significant investment in 21st.BIO A/S – a new D...